Management of chemical dependence in pregnancy.
Although the percentage of pregnant patients who use illicit drugs is relatively low, the effects can be devastating on both mother and fetus-loss of custody, growth restriction, placental abruption, and death. The practicing obstetrician may be unfamiliar with the various presentations of chemical dependency in pregnancy, including intoxication and withdrawal, and difficulty in making the diagnosis. The obstetrician is in the unique situation of being responsible for the safety of both mother and fetus, which may involve engaging the unwilling patient in treatment.
Christensen
Carl
C
Addiction Medicine Services, Detroit Medical Center, Wayne State University, Detroit, Michigan, USA. cchriste@med.wayne.edu
D000437:Alcoholism / Q000150:complications* / Q000517:prevention & control; D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis / Q000517:prevention & control; D006801:Humans; D013287:Illicit Drugs; D007231:Infant, Newborn; D008403:Mass Screening; D009357:Neonatal Abstinence Syndrome / Q000175:diagnosis* / Q000517:prevention & control; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis / Q000517:prevention & control; D011256:Pregnancy Outcome; D018570:Risk Assessment; D012307:Risk Factors; D013375:Substance Withdrawal Syndrome / Q000150:complications; D019966:Substance-Related Disorders / Q000150:complications* / Q000517:prevention & control
D013287:Illicit Drugs